Keyword Analysis & Research: biopharma
Keyword Research: People who searched biopharma also searched
Search Results related to biopharma on Search Engine
-
Biopharmaceutical - Wikipedia
https://en.wikipedia.org/wiki/Biopharmaceutical
Web ResultA biopharmaceutical, also known as a biological medical product, [1] or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources.
DA: 84 PA: 39 MOZ Rank: 50
-
Biotech and Pharma Industry News | BioPharma Dive
https://www.biopharmadive.com/
Web ResultGet the free daily newsletter read by industry experts. BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.
DA: 53 PA: 57 MOZ Rank: 53
-
Rapid growth in biopharma: Challenges and opportunities
https://www.mckinsey.com/industries/life-sciences/our-insights/rapid-growth-in-biopharma
Web ResultDec 1, 2014 · Today, biopharmaceuticals generate global revenues of $163 billion, making up about 20 percent of the pharma market. It’s by far the fastest-growing part of the industry: biopharma’s current annual growth rate of more than 8 percent is double that of conventional pharma, and growth is expected to continue at that …
DA: 43 PA: 55 MOZ Rank: 26
-
AbbVie to Acquire Landos Biopharma, Further Strengthening its …
https://news.abbvie.com/2024-03-25-AbbVie-to-Acquire-Landos-Biopharma,-Further-Strengthening-its-Portfolio-in-Inflammatory-and-Autoimmune-Diseases
Web Result3 days ago · About Landos Biopharma Landos Biopharma is a clinical stage biopharmaceutical company focused on the development of first-in-class, oral therapeutics for patients with autoimmune diseases. Its mission is to create safe and effective oral treatments that address the therapeutic gap in the current treatment …
DA: 2 PA: 11 MOZ Rank: 11
-
Future of biopharma manufacturing | McKinsey
https://www.mckinsey.com/industries/life-sciences/our-insights/reimagining-the-future-of-biopharma-manufacturing
Web ResultOct 11, 2022 · Future of biopharma manufacturing | McKinsey. (7 pages) Over the past two years, the biopharmaceuticals industry has disrupted its established ways of working to deliver on humanitarian needs. New drugs have been approved in months rather than years. Manufacturing capacities have been added in a quarter of the …
DA: 86 PA: 86 MOZ Rank: 36
-
Biopharma 2020: A landmark year and a reset for the future
https://www.mckinsey.com/industries/life-sciences/our-insights/biopharma-2020-a-landmark-year-and-a-reset-for-the-future
Web ResultJan 8, 2021 · The biopharma industry has shown what it can achieve when it works at its best. How can the industry build on this renewed sense of purpose in the years ahead? | McKinsey. (6 pages) More than any year in living memory, 2020 has tested the tenacity and ingenuity of the human spirit.
DA: 57 PA: 89 MOZ Rank: 19
-
Biopharmaceutical benchmarks 2022 | Nature Biotechnology
https://www.nature.com/articles/s41587-022-01582-x
Web ResultDec 5, 2022 · This article is the latest survey of biopharmaceutical approvals, which we conduct every four years. The current survey period (January 2018–June 2022) witnessed the approval of 197 ...
DA: 100 PA: 64 MOZ Rank: 76
-
Biopharma dealmaking in 2023 - Nature
https://www.nature.com/articles/d41573-024-00012-8
Web ResultJan 16, 2024 · Amanda Micklus. The biopharma industry went through a year of transition in 2023. Companies faced challenges, from difficult public financing markets, to venture capitalists who now, more than...
DA: 84 PA: 40 MOZ Rank: 16
-
Progress in biopharmaceutical development - PMC - National …
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749944/
Web ResultNov 2, 2017 · Since its introduction in 1982, biopharmaceutical drugs have revolutionized the treatment of a broad spectrum of diseases and are increasingly used in nearly all branches of medicine.
DA: 44 PA: 86 MOZ Rank: 92
-
For Biopharma, a Rising Tide—and Choppy Waters | BCG
https://www.bcg.com/publications/2022/a-rising-tide-and-choppy-waters-ahead-for-pharmaceutical-companies
Web ResultJun 23, 2022 · First, massive amounts of investment are being funneled into biopharma R&D. Total spending has risen by 7% a year since 2015 to $230 billion in 2021, resulting in more early- and late-stage products in the pipeline than at any time over the past decade.
DA: 16 PA: 5 MOZ Rank: 41